OR WAIT null SECS
November 01, 2018
he acquisition expands the company’s formulation and analytical R&D services.
October 26, 2018
The company added a new EUR 63-million (US$72-million) packaging center at its manufacturing site in Darmstadt, Germany.
October 02, 2018
Engineering controls and safe practices for containment protect both operator and product in tablet and capsule production.
October 01, 2018
The companies partnered to build a 500-L single-use pilot-scale plant for biologics production.
September 28, 2018
A collaboration using Pall’s bioprocessing technology in G-CON’s PODs enables flexible continuous bioprocessing and viral vector facility solutions.
September 26, 2018
Nanjing-based PharmaBlock Sciences acquired a GMP-compliant manufacturing facility in Shangyu, China from Porton Pharma Solutions.
September 20, 2018
The CHF 400-million (US$416-million) investment in Lonza's biopark in Visp, Switzerland, will expand Ibex Solutions with two new offerings, drug substance development and drug substance and drug product manufacturing.
BeiGene is set to build late-stage clinical and commercial production capacity for cancer monoclonal antibodies with GE Healthcare’s KUBio, the prefabricated biopharma facility based on single-use technologies.
The biopharmaceutical company will invest approximately $800 million to expand facilities and manufacturing capacity at its campus in Rensselaer County, NY.
September 19, 2018
The drug particle engineering and nanotechnology company offers a nanotechnology platform that can revive failed drugs in the pharma pipeline.